Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy-Reference-Cited by-同舟云学术

Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy

Published:2015-04 Issue:2 Volume:359 Page:269-274
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Schechter Rebecca B.,Nagilla Madhavi,Joseph Loren,Reddy Poluru,Khattri Arun,Watson Sydeaka,Locati Laura D.,Licitra Lisa,Greco Angela,Pelosi Giuseppe,Carcangiu Maria Luisa,Lingen Mark W.,Seiwert Tanguy Y.,Cohen Ezra E.W.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Multikinase inhibitors in thyroid cancer;Licitra;Ann. Oncol,2012

2. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid;Soh;J. Clin. Endocrinol. Metab,1997

3. Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma;Klein;J. Endocrinol,1999

4. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study;Cohen;J. Clin. Oncol,2008

5. Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study;Bible;Lancet Oncol,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC);Endocrine;2022-06-29

2. Relationship between TSHR, BRAF and PIK3CA gene copy number variations and thyroid nodules;Endocrine;2021-01-11

3. Advanced technological tools to study multidrug resistance in cancer;Drug Resistance Updates;2020-01

4. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis;Cancers;2019-12-30

5. MicroRNA‑9‑5p functions as a tumor suppressor in papillary thyroid cancer via targeting BRAF;Oncology Letters;2018-09-07